<DOC>
	<DOCNO>NCT02925793</DOCNO>
	<brief_summary>The purpose randomize , double blind , placebo control , parallel group study compare safety efficacy topically apply DS107 cream ( 1 % 5 % ) versus vehicle cream , treatment adult patient mild moderate Atopic Dermatitis .</brief_summary>
	<brief_title>Safety Efficacy Study Topically Applied DS107 Cream Mild Moderate Atopic Dermatitis Patients</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Patients clinically confirm diagnosis active Atopic Dermatitis accord Hanifin Rajka criterion Patients mild moderate Atopic Dermatitis baseline define IGA score 2 3 baseline visit Patients Atopic Dermatitis cover minimum 5 % body surface area baseline Male female patient age 18 year old day signing inform consent form ( ICF ) Patients skin condition might interfere Atopic Dermatitis diagnosis and/or evaluation ( psoriasis current active viral , bacterial fungal topical skin infection ) assess Investigator Patients use systemic treatment ( biologics ) could affect Atopic Dermatitis le 4 week prior baseline visit ( Day 0 ) , e.g . retinoids , methotrexate , cyclosporine , hydroxycarbamide ( hydroxyurea ) , azathioprine oral/injectable corticosteroid . Intranasal corticosteroids stable medical condition allow Patients used topical medicate treatment Atopic Dermatitis two week prior start treatment/baseline ( Day 0 ) include limited , topical corticosteroid , calcineurin inhibitor , tar , bleach , antimicrobial , bleach baths Patients use topical product contain urea , ceramides hyaluronic acid two week prior Day 0 Patients history hypersensitivity substance DS107 cream vehicle cream Patients clinically significant control uncontrolled medical condition laboratory abnormality would , opinion Investigator , put patient undue risk interfere interpretation study result Patients significant uncontrolled cardiovascular , neurologic , malignant , psychiatric , respiratory hypertensive disease , well uncontrolled diabetes floride arthritis illness , opinion Investigator , likely interfere completion study Patients chronic infectious disease ( e.g . hepatitis B , hepatitis C , infection human immunodeficiency virus )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>